Dyskinesia and neuroleptics.
D000328:Adult; D002746:Chlorpromazine / Q000627:therapeutic use; D002908:Chronic Disease; D005476:Fluphenazine / Q000627:therapeutic use; D006760:Hospitalization; D006801:Humans; D008297:Male; D008875:Middle Aged; D009069:Movement Disorders / Q000139:chemically induced*; D010640:Phenothiazines / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000627:therapeutic use; D014149:Tranquilizing Agents / Q000009:adverse effects* / Q000627:therapeutic use; D014268:Trifluoperazine / Q000627:therapeutic use; D014421:Turkey; D014481:United States
D010640:Phenothiazines; D014149:Tranquilizing Agents; D014268:Trifluoperazine; D013881:Thioridazine; D005476:Fluphenazine; D002746:Chlorpromazine